HealthLynked Corp (HLYK) Financial Statements (2026 and earlier)

Company Profile

Business Address 1265 CREEKSIDE PARKWAY
NAPLES, FL 34108
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 8011 - Offices and Clinics of Doctors of Medicine (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3776247623,292162
Cash and cash equivalent3776247623,292162
Receivables   1,874728687
Inventory, net of allowances, customer advances and progress billings184513319313595
Inventory184513319313595
Prepaid expense33   125 
Asset, held-for-sale, not part of disposal group    1,455  
Other current assets  101    
Other undisclosed current assets1,4641,419(1,598)3631359
Total current assets:1,5521,6416562,1453,650404
Noncurrent Assets
Operating lease, right-of-use asset76361936540  
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization75177291413350437
Intangible asset, including goodwill, after accumulated amortization   1,2041,4326,0286,750
Goodwill   3203201,1481,148
Intangible asset, excluding goodwill, after accumulated amortization   8841,1124,8805,602
Regulated entity, other noncurrent assets   166   
Deposits noncurrent assets  44  139 
Other undisclosed noncurrent assets   1,02751527436
Total noncurrent assets:1515823,6242,4367,0447,623
TOTAL ASSETS:1,7022,2234,2804,58110,6958,027
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:8217656121,6037911,892
Accounts payable531469251864306 
Accrued liabilities1779091673173 
Other undisclosed accounts payable and accrued liabilities114206269663121,892
Deferred revenue262332725757389
Debt39012758445061723
Deferred compensation liability 301301 75  
Derivative instruments and hedges, liabilities24    89
Disposal group, including discontinued operation    25  
Business combination, contingent consideration, liability    100403702
Other liabilities   2   
Due to related parties168301301
Other undisclosed current liabilities5,4523,2649424792891,086
Total current liabilities:7,0134,6902,4123,4751,9184,882
Noncurrent Liabilities
Long-term debt and lease obligation    45378996
Long-term debt, excluding current maturities    45139723
Liabilities, other than long-term debt451154613198  
Operating lease, liability 1154613198239274
Government assistance, liability450 
Other undisclosed noncurrent liabilities  509450548956525
Total noncurrent liabilities:4516621,0637921,5731,795
Total liabilities:7,4645,3523,4754,2663,4916,677
Equity
Equity, attributable to parent, including:(5,762)(3,129)8053147,2041,350
Preferred stock333333
Common stock02828262419
Additional paid in capital44,71344,84342,52641,08139,10022,851
Deferred compensation equity   (65) (151) 
Accumulated deficit(50,539)(48,165)(42,033)(41,021)(32,205)(21,785)
Other undisclosed equity, attributable to parent61162346226434262
Total equity:(5,762)(3,129)8053147,2041,350
TOTAL LIABILITIES AND EQUITY:1,7022,2234,2804,58110,6958,027

Income Statement (P&L) ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues2,0653,0085,7225,8589,1986,133
Cost of revenue
(Other Cost of Operating Revenue)
    (340)  
Gross profit:2,0653,0085,7225,5189,1986,133
Operating expenses(4,179)(7,686)(9,874)(14,518)(14,241)(9,205)
Other undisclosed operating income    340  
Operating loss:(2,113)(4,678)(4,152)(8,659)(5,043)(3,072)
Nonoperating income (expense)(1,167)(1,454)538(23)(5,369)(2,683)
Gain on condemnation   1,091   
Debt instrument, convertible, beneficial conversion feature     825 
Interest and debt expense(618)84(21)(431)(4,957)(382)
Loss from continuing operations before equity method investments, income taxes:(3,898)(6,047)(3,635)(9,113)(15,370)(6,137)
Other undisclosed income (loss) from continuing operations before income taxes  (84)211,0454,957382
Loss from continuing operations:(3,898)(6,131)(3,614)(8,067)(10,413)(5,755)
Loss before gain (loss) on sale of properties:(10,413)(5,755)
Income (loss) from discontinued operations   2,602(748)  
Net loss:(3,898)(6,131)(1,012)(8,816)(10,413)(5,755)
Other undisclosed net income attributable to parent618     
Net loss attributable to parent:(3,280)(6,131)(1,012)(8,816)(10,413)(5,755)
Preferred stock dividends and other adjustments      (446)
Other undisclosed net loss available to common stockholders, basic   (354)(354) 
Net loss available to common stockholders, diluted:(3,280)(6,131)(1,012)(9,169)(10,766)(6,201)

Comprehensive Income ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(3,898)(6,131)(1,012)(8,816)(10,413)(5,755)
Comprehensive loss, net of tax, attributable to parent:(3,898)(6,131)(1,012)(8,816)(10,413)(5,755)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: